-
Our Mission:
Ensure that essential
generic medications are
available & affordable
to everyone.Civica Rx is a new enterprise designed to reduce chronic generic drug shortages that have become a national crisis and have negatively impacted patient care for over a decade…
Civica Rx exists in the public interest as a non-profit, non-stock corporation committed to stabilizing supply of essential generic medications in a hospital setting…
Civica Rx was founded by leading U.S. health systems concerned about predatory pricing and drug shortages and philanthropic organizations passionate about improving healthcare…
Civica Rx will act in the best interest of patients to eliminate uncertainty in the generic drug supply chain through long-term contracts with the health system members who have joined Civica Rx as well as its manufacturing partners…
Civica Rx is committed to transparency, will offer fair and sustainable prices, and will ensure it has dedicated manufacturing capacity for the medications that are most desperately needed in hospitals across the country.
Over 35 health systems and philanthropies are now a part of Civica, including:
.
Advocate Aurora Health
Allegheny Health Network
Aspirus Health System
Baptist Health
Baptist Health South Florida
Christiana Care Health System
CommonSpirit Health
Franciscan Alliance
Gary and Mary West Foundation
Hospital Corporation of America (HCA)
Hospital Sisters Health System
Integris Health
Intermountain Healthcare
Laura and John Arnold Foundation
Mayo Clinic
MemorialCare
Memorial Hermann
New Hanover Regional Medical Center
North Memorial Hospital
NYU Langone Health
Ochsner Health System
Peterson Center on Healthcare
Piedmont Health
Providence St. Joseph Health
Regional One Health
Sanford Health
Southeast Georgia Health System
Spectrum Health
SSM Health
St. Clair Hospital
Steward Health Care System
St. Luke's University Health Network
The Christ Hospital
ThedaCare
Trinity Health
UnityPoint Health
University of Utah Health
Recent News
Hikma and Civica Rx Sign Long-term Agreement
Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company and Civica Rx, today announce a five-year agreement to manufacture and supply Civica's growing membership of US health systems with medications that are often in short supply in US hospitals. Under the agreement, Hikma will produce 14 essential sterile injectable medications for Civica as a private...
Vizient Announces It Will Help Civica Reduce Drug Shortages
Vizient, based in Irving Texas, will provide insights into purchasing patterns and provider needs through their analytics and data capabilities, helping Civica anticipate gaps in drug availability and affordability. “We applaud Vizient for helping to find innovative ways to reduce drug shortages through their analytics and data expertise,” said Martin VanTrieste, Civica CEO. “The...
Civica Rx and Xellia Pharmaceuticals Join Forces
Civica Rx announces its first supplier partner, Xellia Pharmaceuticals. Xellia will manufacture essential antibiotics, including Vancomycin and Daptomycin, for Civica’s member health systems to address shortages of these anti-infective medications and improve patient care in hospitals across the US. Today marks the first time that Civica is announcing the production of generic drugs –...
Civica will partner with healthcare systems to ensure that generic drugs are affordable and available as soon as possible.
We will partner with hospitals and healthcare systems to (1) prioritize production of generic drugs and (2) purchase Civica generic drugs, based on hospital systems’ clinical needs.
- We will create market stability by procuring or manufacturing the products required by our hospital systems
- We will guarantee volumes for our hospitals and health system partners for each drug we manufacture
Civica will focus on bringing value — in supply, quality, and price — to the market
- We will establish long-term partnerships that will allow us to guarantee predictable, long-term supply
- We will provide our suppliers with long-term, predictable volumes
- We will work with trusted, FDA-approved manufacturers with high-quality track records. We will embed a collaborative, rigorous quality assurance process with each partner and will have a single price point for each drug, regardless of health system size
- We will assure that our prices are transparent and competitive
Civica will serve as a check in the generic manufacturing industry
- We will fix broken markets by applying for Abbreviated New Drug Applications (ANDA) for each drug we manufacture
- We will have the R&D expertise necessary to enter identified drug markets and develop medications that our patients need
- We will partner with our governmental and regulatory agencies to assure we are working together in a way that benefits our patients